IIM
XERS icon

INTECH Investment Management’s Xeris Biopharma Holdings XERS Stock Holding History

INTECH Investment Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$210K Sell
36,241
-28,849
-44% -$191K ﹤0.01% 1732
2025
Q4 		$511K Buy
65,090
+9,754
+18% +$76.8K ﹤0.01% 1507
2025
Q3 		$450K Sell
55,336
-39,101
-41% -$260K ﹤0.01% 1635
2025
Q2 		$441K Buy
94,437
+44,330
+88% +$203K ﹤0.01% 1677
2025
Q1 		$275K Sell
50,107
-8,841
-15% -$35.7K ﹤0.01% 1938
2024
Q4 		$200K Buy
58,948
+13,340
+29% +$42.9K ﹤0.01% 2034
2024
Q3 		$130K Buy
+45,608
New +$117K ﹤0.01% 1837

Other funds holding XERS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $244M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return